Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)

The new coronavirus infection (SARS-CoV-2), better known as COVID-19, quickly evolved into a worldwide pandemic with a significant public health burden. Currently, there are no approved drugs or preventive therapeutic strategies to combat infection. Decisions about prescribing many medications are m...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ya. E. Shirobokov, E. P. Gladunova, E. A. Borodulina, A. E. Sukhanova
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2021
Materias:	covid-19 sars-cov-2 systematic review randomized controlled trial Science Q
Acceso en línea:	https://doaj.org/article/dceaf9e786774c56b29d74e5a0179e88
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dceaf9e786774c56b29d74e5a0179e88
record_format	dspace
spelling	oai:doaj.org-article:dceaf9e786774c56b29d74e5a0179e882021-11-23T06:14:46ZOverview of potential drugs for the treatment of new coronavirus Infection (COVID-19)2541-94202587-959610.29413/ABS.2021-6.4.7https://doaj.org/article/dceaf9e786774c56b29d74e5a0179e882021-10-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/2975https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The new coronavirus infection (SARS-CoV-2), better known as COVID-19, quickly evolved into a worldwide pandemic with a significant public health burden. Currently, there are no approved drugs or preventive therapeutic strategies to combat infection. Decisions about prescribing many medications are made based on the results obtained in in vitro studies, or expert opinions. Most of the drugs currently used to treat COVID-19 are approved antivirals or antibodies against other diseases. However, there are hundreds of clinical studies underway around the world to discover effective treatments for COVID-19. This article summarizes the results of clinical studies of potential therapeutic drugs used as COVID-19 therapy. Based on this review, it can be concluded that there is still no high-quality evidence to support any of the drugs described below. Until the unambiguous results of randomized controlled trials are available, the use of any of the following drugs is not clinically proven as an effective treatment for COVID-19.Ya. E. ShirobokovE. P. GladunovaE. A. BorodulinaA. E. SukhanovaScientific Сentre for Family Health and Human Reproduction Problemsarticlecovid-19sars-cov-2systematic reviewrandomized controlled trialScienceQRUActa Biomedica Scientifica, Vol 6, Iss 4, Pp 74-86 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	covid-19 sars-cov-2 systematic review randomized controlled trial Science Q
spellingShingle	covid-19 sars-cov-2 systematic review randomized controlled trial Science Q Ya. E. Shirobokov E. P. Gladunova E. A. Borodulina A. E. Sukhanova Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
description	The new coronavirus infection (SARS-CoV-2), better known as COVID-19, quickly evolved into a worldwide pandemic with a significant public health burden. Currently, there are no approved drugs or preventive therapeutic strategies to combat infection. Decisions about prescribing many medications are made based on the results obtained in in vitro studies, or expert opinions. Most of the drugs currently used to treat COVID-19 are approved antivirals or antibodies against other diseases. However, there are hundreds of clinical studies underway around the world to discover effective treatments for COVID-19. This article summarizes the results of clinical studies of potential therapeutic drugs used as COVID-19 therapy. Based on this review, it can be concluded that there is still no high-quality evidence to support any of the drugs described below. Until the unambiguous results of randomized controlled trials are available, the use of any of the following drugs is not clinically proven as an effective treatment for COVID-19.
format	article
author	Ya. E. Shirobokov E. P. Gladunova E. A. Borodulina A. E. Sukhanova
author_facet	Ya. E. Shirobokov E. P. Gladunova E. A. Borodulina A. E. Sukhanova
author_sort	Ya. E. Shirobokov
title	Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
title_short	Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
title_full	Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
title_fullStr	Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
title_full_unstemmed	Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)
title_sort	overview of potential drugs for the treatment of new coronavirus infection (covid-19)
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2021
url	https://doaj.org/article/dceaf9e786774c56b29d74e5a0179e88
work_keys_str_mv	AT yaeshirobokov overviewofpotentialdrugsforthetreatmentofnewcoronavirusinfectioncovid19 AT epgladunova overviewofpotentialdrugsforthetreatmentofnewcoronavirusinfectioncovid19 AT eaborodulina overviewofpotentialdrugsforthetreatmentofnewcoronavirusinfectioncovid19 AT aesukhanova overviewofpotentialdrugsforthetreatmentofnewcoronavirusinfectioncovid19
_version_	1718416915235340288

Overview of potential drugs for the treatment of new coronavirus Infection (COVID-19)

Ejemplares similares